Robertson et al., 1994 - Google Patents
Simultaneous treatment of calcium oxalate and uric acid stone disease in Saudi ArabiaRobertson et al., 1994
- Document ID
- 14476411427823651359
- Author
- Robertson W
- Hughes H
- Husain I
- Al-Faqih S
- Arafat A
- Chakrabarti A
- Shamsuddin A
- Tipton L
- Publication year
- Publication venue
- Urolithiasis 2
External Links
Snippet
Urolithiasis is a major public health problem in most of the oil-rich Gulf countries. In Saudi Arabia, for example, it is estimated that over 20% of men will have at least one episode of stones before the age of 60. The majority of stones are idiopathic in origin and consist of …
- 239000004575 stone 0 title abstract description 28
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/30—Zinc; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
- A61K33/08—Oxides; Hydroxides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/34—Copper; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/42—Phosphorus; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2614909B2 (en) | Liquid calcium supplementation from readily soluble mixtures of calcium compounds and citric acid | |
| Lindberg et al. | Magnesium bioavailability from magnesium citrate and magnesium oxide. | |
| Heilberg et al. | Renal stone disease: Causes, evaluation and medical treatment | |
| Heizer et al. | Intestinal effects of sulfate in drinking water on normal human subjects | |
| Doscherholmen et al. | Impaired assimilation of egg Co57 vitamin B12 in patients with hypochlorhydria and achlorhydria and after gastric resection | |
| Bataille et al. | Diet, vitamin D and vertebral mineral density in hypercalciuric calcium stone formers | |
| Preminger et al. | Alkali action on the urinary crystallization of calcium salts: contrasting responses to sodium citrate and potassium citrate | |
| Michelis et al. | Decreased bicarbonate threshold and renal magnesium wasting in a sibship with distal renal tubular acidosis: Evaluation of the pathophysiologic role of parathyroid hormone | |
| Lindberg et al. | Effect of magnesium citrate and magnesium oxide on the crystallization of calcium salts in urine: changes produced by food-magnesium interaction | |
| Whalley et al. | Long‐term effects of potassium citrate therapy on the formation of new stones in groups of recurrent stone formers with hypocitraturia | |
| Pak et al. | Dietary management of idiopathic calcium urolithiasis | |
| Freeland-Graves et al. | Plasma uptake of manganese as affected by oral loads of manganese, calcium, milk, phosphorus, copper, and zinc. | |
| JPH1067666A (en) | Medicinal or diet therapy composition | |
| JPS62501846A (en) | liquid dietary calcium supplement | |
| Clark et al. | Nephrolithiasis in childhood inflammatory bowel disease | |
| Spencer et al. | Osteoporosis: calcium, fluoride, and aluminum interactions. | |
| Konnak et al. | Renal calculi associated with incomplete distal renal tubular acidosis | |
| Grove et al. | Experimental urolithiasis. II. The influence of urine volume upon calculi experimentally produced upon foreign bodies | |
| Jeppsson et al. | The influence of food on side effects and absorption of lithium | |
| Spencer et al. | Studies of fluoride metabolism in man: a review and report of original data | |
| Robertson et al. | Simultaneous treatment of calcium oxalate and uric acid stone disease in Saudi Arabia | |
| Schuette et al. | The effect of carbohydrates in milk on the absorption of calcium by postmenopausal women. | |
| Martz et al. | Use of a combination of anion and cation exchange resins in the treatment of edema and ascites | |
| Bloomer et al. | The Fanconi syndrome with renal hyperchloremic acidosis: Sequential development of multiple tubular dysfunctions in a child | |
| Stapleton | Idiopathic hypercalciuria in children |